BRAIN CANCER

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
https://www.ncbi.nlm.nih.gov/pubmed/29621254

Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
https://www.ncbi.nlm.nih.gov/pubmed/27035164

Expression and structure of interleukin 4 receptors in primary meningeal tumors
http://www.ncbi.nlm.nih.gov/pubmed/15830341

Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas
http://www.ncbi.nlm.nih.gov/pubmed/17398005

Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.
http://www.ncbi.nlm.nih.gov/pubmed/11217365

Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma
http://www.ncbi.nlm.nih.gov/pubmed/14531567

Convection-enhanced Delivery of Free Gadolinium with the Experimental Chemotherapeutic Agent PRX321
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150410/

Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy
http://www.ncbi.nlm.nih.gov/pubmed/9721874

In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures
http://www.ncbi.nlm.nih.gov/pubmed/11719427

IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein
http://www.ncbi.nlm.nih.gov/pubmed/11870521

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant
glioma therapy
http://www.ncbi.nlm.nih.gov/pubmed/14649882

Convection-Enhanced Drug Delivery of Interleukin-4 Pseudomonas Exotoxin (PRX321): Increased Distribution and Magnetic Resonance Monitoring
http://www.ncbi.nlm.nih.gov/pubmed/19478131

Toxicologic Pathology of Cytokines, Cytokine Receptors, and Other Recombinant Human Proteins – Development of a Recombinant Interleukin-4-Pseudomonas Exotoxin for Therapy of Glioblastoma
http://www.ncbi.nlm.nih.gov/pubmed/10367674

Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein
http://www.ncbi.nlm.nih.gov/pubmed/8056454

Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma
http://www.ncbi.nlm.nih.gov/pubmed/8971168

A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
http://www.ncbi.nlm.nih.gov/pubmed/19689300

Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001)
http://www.ncbi.nlm.nih.gov/pubmed/15015787

Clinical Studies with Targeted Toxins in Malignant Glioma
http://www.ncbi.nlm.nih.gov/pubmed/18473963

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma
http://www.ncbi.nlm.nih.gov/pubmed/10873064

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy
http://www.ncbi.nlm.nih.gov/pubmed/16709016

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin
(NBI-3001) in patients with recurrent malignant glioma
http://www.ncbi.nlm.nih.gov/pubmed/12952293

A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery
http://www.ncbi.nlm.nih.gov/pubmed/12427253